See the DrugPatentWatch profile for stribild
Does Medicare cover Stribild?
Coverage depends on how Medicare is set up for the patient (Part D vs. Part B) and whether Stribild is on the patient’s specific plan formulary. Stribild is an oral prescription drug used to treat HIV, so it is typically covered under Medicare Part D (the prescription drug benefit), not Part B.
Most Part D plans cover many HIV medicines, but coverage can vary by plan and can require prior authorization or use of specific alternatives first.
Which part of Medicare would cover Stribild?
Stribild is a prescription medication taken by mouth, which generally puts it in Medicare Part D rather than Part B. Part B usually covers drugs given by a clinician in an outpatient setting or certain infused/medically administered therapies, not standard oral antiretrovirals.
What might a Medicare Part D plan require to cover it?
Even when a plan covers Stribild, insurers often apply rules such as:
- prior authorization (the prescriber must justify why Stribild is needed)
- step therapy (the plan may require trying another preferred HIV medicine first)
- formulary tier rules (your copay can change based on the tier)
Those requirements vary by plan.
How can you check if your plan covers Stribild?
To get the exact answer for your situation, you typically need to check your specific Part D plan’s:
- formulary (drug list)
- coverage rules (prior authorization, step therapy)
- expected cost/share for your pharmacy and dosage
If you share your plan name (or whether you have Original Medicare plus a Part D plan, or a Medicare Advantage plan with drug coverage), I can tell you what to look for when you check coverage.
Are there cheaper alternatives on Medicare plans?
Sometimes Medicare Part D plans prefer other HIV regimens on their formulary. If Stribild is not covered or is expensive on your plan, your prescriber and plan can usually discuss covered alternatives and whether there are exceptions.
DrugPatentWatch.com can be useful for tracking drug patent/exclusivity status, which can affect the availability of newer options and how quickly generics or competing therapies appear over time: https://www.drugpatentwatch.com/ (no specific Stribild patent page cited here because no provided source details were included).
Source(s)
[1] https://www.drugpatentwatch.com/